Home›Stock Screener›Biocon›Quarterly Results

Biocon Quarterly Results for Trading Insights

Latest Quarter Net Profit
₹199 Cr
QMar 2026
Quarterly Results

In Mar 2026, Biocon (BIOCON) reported revenue ₹4,537 Cr and net profit ₹199 Cr — revenue +2.8% YoY. For annual financials, live price and key ratios, visit BIOCON share price.

BIOCON Quarterly Results — Revenue, Profit & EPS Highlights

Biocon latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Check Biocon market worth to track the company's total market size over time.

  • Revenue of ₹4,537 Cr in Mar 2026 (+4.4% vs Jun 2026, +2.8% vs Mar 2025)
  • Net Profit of ₹199 Cr in Mar 2026 (+45.3% vs Jun 2026, -56.6% vs Mar 2025)
  • EBITDA of ₹960 Cr in Mar 2026 (+13.7% vs Jun 2026)
  • Operating Margin of 20.0% in Mar 2026 (+2.0pp vs Jun 2026)
  • Earnings Per Share of ₹0.79 in Mar 2026 (-9.2% vs Jun 2026)

Biocon Quarterly Results — Revenue, EBITDA, Net Profit & EPS

BIOCON quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Mar 2026 Jun 2026 Sept 2025 Mar 2025 Jun 2025 QoQ YoY
Revenue (₹ Cr) 4,537 4,346 4,356 4,415 3,990 4.4% 2.8%
Net Profit (₹ Cr) 199 137 133 459 89 - -
EBITDA (₹ Cr) 960 844 884 1,077 797 - -
EPS (₹) 0.79 0.87 0.66 2.88 0.26 - -
Operating Margin (%) 20.0% 18.0% 19.0% 23.0% 18.0% - -

BIOCON Share Price Trend — 1-Year Movement Across Quarterly Results

Biocon 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Analyse Biocon ownership pattern to track promoter, FII and institutional holdings.

Profitability Ratios

Profit Margin 4.4%
EBITDA Margin 21.2%
Operating Margin 20.0%
ROE (Annual) 2.2%

Balance Sheet Highlights

Total Assets ₹63,651 Cr
Total Equity ₹36,622 Cr
Current Assets ₹17,180 Cr
Current Liabilities ₹12,960 Cr

Cash Flow Analysis

Operating Cash Flow ₹1,994 Cr
Investing Cash Flow ₹-1,883 Cr
Financing Cash Flow ₹-924 Cr
Net Cash Flow ₹-812 Cr

Current Market Data

Current Price ₹415.55
Exchange NSE
Last Updated Aug 21, 2026

Revenue Trend (₹ Cr)

Mar 2025 4,415
Sept 2025 4,356
Jun 2026 4,346
Mar 2026 4,537

Net Profit Trend (₹ Cr)

Mar 2025 459
Sept 2025 133
Jun 2026 137
Mar 2026 199

Operating Margin Trend (%)

Mar 2025 23.0%
Sept 2025 19.0%
Jun 2026 18.0%
Mar 2026 20.0%

BIOCON vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Biocon latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Mar 2026 		₹463,071.60 Cr 1902.4 15,018 2,710 -5.6% - 18.0% 168.4
Divis Laboratories
Mar 2026 		₹225,157.18 Cr 8597.0 2,986 751 -5.0% - 25.2% 303.7
Torrent Pharmaceuti…
Mar 2026 		₹188,719.51 Cr 4896.5 4,111 364 +27.7% +42.2% 8.9% 425.4
Cipla
Mar 2026 		₹115,699.61 Cr 1432.2 6,612 543 -9.3% - 8.2% 208.5
Zydus Life Science
Mar 2026 		₹113,855.38 Cr 1120.0 7,569 1,341 -4.3% - 17.7% 88.5
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores